Anatara Lifesciences Share Price and Company Fundamentals



Price
$0.145
Change
0.000 (0.000%)
52 week
0.14 - 0.28

Last traded: Today at 5:10 AM

Anatara Lifesciences Limited engages in the research and development of evidence based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming (GaRP), a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD); and 3FDC for the treatment of anxiety, stress, or depression. The company also provides Detach for the treatment of diarrhea disease in piglets. In addition, it is developing bromelain-based formulations for piglets and poultry. Anatara Lifesciences Limited was incorporated in 2010 and is based in Carlton, Australia.

Key Metrics

PE ratio

-

PB ratio

2.60

Dividend yield

Beta

1.06

Market cap

$9.94M

Enterprise value

$6.59M

Company profile

Primary activitiesDeveloping non-antibiotic oral solutions for gastrointestinal diseases in animals and humans.
Industry / SectorBiotechnology / Healthcare
Websitehttp://www.anataralifesciences.com
Mailing address62 Lygon Street Level 3 Carlton VIC 3053 Australia
Phone / Fax61 3 9824 5454 /
Share registryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED

Dividends

Anatara Lifesciences does not pay dividends.

Company Executives

As of Oct 2021, following are the company executives and directors listed on Anatara Lifesciences.

NameTitleAgeTotal Pay
Mr. Steven George Lydeamore C.P.A., CPA, M.B.A., MBAChief Exec. Officer425.1k
Dr. Michael L. WestChief Operating Officer56292.98k
Jane LoweManaging Director of IR Department
Dr. Stephen Denaro AGIA, BCom, GradDipApp CG, CA, MAICDCompany Sec.
Ms. Hayley van der Meer B Biomed Sc, Grad Dip Marketing ManagementCommercial Mang.

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

0.00%

Return on assets

-33.28%

Return on equity

-59.70%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Anatara Lifesciences is 9.94M and its enterprise value is 6.59M. The enterprise value to revenue ratio of ANR is 6.23.

The ANR's stocks Beta value is 1.06 making it 6% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Anatara Lifesciences (ANR)

Anatara Lifesciences (ASX:ANR) Frequently Asked Questions

1. What is Anatara Lifesciences's Stock Symbol?

Anatara Lifesciences trades on ASX under the ticker symbol "ANR".

2. What is Anatara Lifesciences's stock price today?

One share of ANR stock can currently be purchased for approximately $0.145.

3. How can I contact Anatara Lifesciences?

Anatara Lifesciences's mailing address is 62 Lygon Street Level 3 Carlton VIC 3053 Australia. The company can be reached via phone at 61 3 9824 5454.

4. What is Anatara Lifesciences's official website?

The official website of Anatara Lifesciences is http://www.anataralifesciences.com.

5. Which share registry manages Anatara Lifesciences's stock?

Anatara Lifesciences's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.